Publication Information

{'id': 'https://openalex.org/W2470591393', 'doi': 'https://doi.org/10.2174/138161210794079191', 'title': 'Editorial [Hot topic:Sealing the Envelope – the HIV-1 Envelope Glycoproteins as Targets for Therapeutics and Vaccines (Executive Editors: Rogier W. Sanders, Ben Berkhout)]', 'display_name': 'Editorial [Hot topic:Sealing the Envelope – the HIV-1 Envelope Glycoproteins as Targets for Therapeutics and Vaccines (Executive Editors: Rogier W. Sanders, Ben Berkhout)]', 'publication_year': 2010, 'publication_date': '2010-11-01', 'ids': {'openalex': 'https://openalex.org/W2470591393', 'doi': 'https://doi.org/10.2174/138161210794079191', 'mag': '2470591393', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21128883'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.2174/138161210794079191', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S55674637', 'display_name': 'Current Pharmaceutical Design', 'issn_l': '1381-6128', 'issn': ['1381-6128', '1873-4286'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320079', 'host_organization_name': 'Bentham Science Publishers', 'host_organization_lineage': ['https://openalex.org/P4310320079'], 'host_organization_lineage_names': ['Bentham Science Publishers'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'editorial', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5087473572', 'display_name': 'Rogier W. Sanders', 'orcid': 'https://orcid.org/0000-0002-2324-8573'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Rogier W. Sanders', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5019287445', 'display_name': 'Ben Berkhout', 'orcid': 'https://orcid.org/0000-0002-1905-8486'}, 'institutions': [{'id': 'https://openalex.org/I2802928900', 'display_name': 'Academic Medical Center', 'ror': 'https://ror.org/03t4gr691', 'country_code': 'NL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802928900', 'https://openalex.org/I4210151833']}, {'id': 'https://openalex.org/I205783295', 'display_name': 'Cornell University', 'ror': 'https://ror.org/05bnh6r87', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I205783295']}, {'id': 'https://openalex.org/I887064364', 'display_name': 'University of Amsterdam', 'ror': 'https://ror.org/04dkp9463', 'country_code': 'NL', 'type': 'education', 'lineage': ['https://openalex.org/I887064364']}], 'countries': ['NL', 'US'], 'is_corresponding': True, 'raw_author_name': 'Ben Berkhout', 'raw_affiliation_strings': ['Department of Microbiology and Immunology Weill Medical College of Cornell University New York, USA. Laboratory of Experimental Virology Department of Medical Microbiology Academic Medical Center of the University of Amsterdam, The Netherlands.,Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Department of Microbiology and Immunology Weill Medical College of Cornell University New York, USA. Laboratory of Experimental Virology Department of Medical Microbiology Academic Medical Center of the University of Amsterdam, The Netherlands.,Netherlands', 'institution_ids': ['https://openalex.org/I2802928900', 'https://openalex.org/I205783295', 'https://openalex.org/I887064364']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5019287445'], 'corresponding_institution_ids': ['https://openalex.org/I2802928900', 'https://openalex.org/I205783295', 'https://openalex.org/I887064364'], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': '16', 'issue': '33', 'first_page': '3699', 'last_page': '3700'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9877, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9877, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9758, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9117, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/maraviroc', 'display_name': 'Maraviroc', 'score': 0.9312455}, {'id': 'https://openalex.org/keywords/enfuvirtide', 'display_name': 'Enfuvirtide', 'score': 0.92019284}, {'id': 'https://openalex.org/keywords/entry-inhibitor', 'display_name': 'Entry inhibitor', 'score': 0.59091985}, {'id': 'https://openalex.org/keywords/ccr5-receptor-antagonist', 'display_name': 'CCR5 receptor antagonist', 'score': 0.50433457}], 'concepts': [{'id': 'https://openalex.org/C2778899366', 'wikidata': 'https://www.wikidata.org/wiki/Q421369', 'display_name': 'Maraviroc', 'level': 3, 'score': 0.9312455}, {'id': 'https://openalex.org/C2778037500', 'wikidata': 'https://www.wikidata.org/wiki/Q423327', 'display_name': 'Enfuvirtide', 'level': 5, 'score': 0.92019284}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.7010691}, {'id': 'https://openalex.org/C108625454', 'wikidata': 'https://www.wikidata.org/wiki/Q187126', 'display_name': 'Glycoprotein', 'level': 2, 'score': 0.6954873}, {'id': 'https://openalex.org/C97380033', 'wikidata': 'https://www.wikidata.org/wiki/Q994215', 'display_name': 'Viral envelope', 'level': 3, 'score': 0.6467062}, {'id': 'https://openalex.org/C58475186', 'wikidata': 'https://www.wikidata.org/wiki/Q4118894', 'display_name': 'Viral entry', 'level': 4, 'score': 0.6404791}, {'id': 'https://openalex.org/C2776997796', 'wikidata': 'https://www.wikidata.org/wiki/Q1345259', 'display_name': 'Entry inhibitor', 'level': 5, 'score': 0.59091985}, {'id': 'https://openalex.org/C37044404', 'wikidata': 'https://www.wikidata.org/wiki/Q5009692', 'display_name': 'CCR5 receptor antagonist', 'level': 5, 'score': 0.50433457}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.48245865}, {'id': 'https://openalex.org/C103038307', 'wikidata': 'https://www.wikidata.org/wiki/Q6556360', 'display_name': 'Lipid bilayer fusion', 'level': 3, 'score': 0.4517528}, {'id': 'https://openalex.org/C2522874641', 'wikidata': 'https://www.wikidata.org/wiki/Q808', 'display_name': 'Virus', 'level': 2, 'score': 0.4504944}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.41120046}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.36935574}, {'id': 'https://openalex.org/C140704245', 'wikidata': 'https://www.wikidata.org/wiki/Q3933202', 'display_name': 'Viral replication', 'level': 3, 'score': 0.26767802}, {'id': 'https://openalex.org/C2776258796', 'wikidata': 'https://www.wikidata.org/wiki/Q5590520', 'display_name': 'Gp41', 'level': 4, 'score': 0.25289708}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.25132242}, {'id': 'https://openalex.org/C147483822', 'wikidata': 'https://www.wikidata.org/wiki/Q103537', 'display_name': 'Antigen', 'level': 2, 'score': 0.17275822}, {'id': 'https://openalex.org/C195616568', 'wikidata': 'https://www.wikidata.org/wiki/Q128711', 'display_name': 'Epitope', 'level': 3, 'score': 0.09286329}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.08655414}, {'id': 'https://openalex.org/C2776914184', 'wikidata': 'https://www.wikidata.org/wiki/Q101991', 'display_name': 'Inflammation', 'level': 2, 'score': 0.07865691}, {'id': 'https://openalex.org/C13373296', 'wikidata': 'https://www.wikidata.org/wiki/Q421866', 'display_name': 'Chemokine', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C12823836', 'wikidata': 'https://www.wikidata.org/wiki/Q24720618', 'display_name': 'Chemokine receptor', 'level': 4, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D054299', 'descriptor_name': 'env Gene Products, Human Immunodeficiency Virus', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D016915', 'descriptor_name': 'AIDS Vaccines', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': False}, {'descriptor_ui': 'D016915', 'descriptor_name': 'AIDS Vaccines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015483', 'descriptor_name': 'HIV Antibodies', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D015483', 'descriptor_name': 'HIV Antibodies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023581', 'descriptor_name': 'HIV Fusion Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D023581', 'descriptor_name': 'HIV Fusion Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023581', 'descriptor_name': 'HIV Fusion Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': False}, {'descriptor_ui': 'D015658', 'descriptor_name': 'HIV Infections', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058990', 'descriptor_name': 'Molecular Targeted Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054299', 'descriptor_name': 'env Gene Products, Human Immunodeficiency Virus', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D054299', 'descriptor_name': 'env Gene Products, Human Immunodeficiency Virus', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': False}, {'descriptor_ui': 'D054299', 'descriptor_name': 'env Gene Products, Human Immunodeficiency Virus', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.2174/138161210794079191', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S55674637', 'display_name': 'Current Pharmaceutical Design', 'issn_l': '1381-6128', 'issn': ['1381-6128', '1873-4286'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320079', 'host_organization_name': 'Bentham Science Publishers', 'host_organization_lineage': ['https://openalex.org/P4310320079'], 'host_organization_lineage_names': ['Bentham Science Publishers'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21128883', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.79}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4301420906', 'https://openalex.org/W4211010080', 'https://openalex.org/W2684946769', 'https://openalex.org/W242113776', 'https://openalex.org/W2164681352', 'https://openalex.org/W2155601765', 'https://openalex.org/W2145684699', 'https://openalex.org/W2034799492', 'https://openalex.org/W2031720554', 'https://openalex.org/W2014733693'], 'abstract_inverted_index': {'HIV-1': [0, 63], 'is': [1, 31], 'an': [2, 33], 'enveloped': [3], 'virus': [4, 12], 'that': [5], 'derives': [6], 'its': [7], 'lipid': [8], 'envelope': [9, 16], 'from': [10], 'the': [11, 45, 76, 86, 94, 111], 'producing': [13], 'cell.': [14], 'The': [15, 39, 81], 'glycoprotein': [17], 'complex': [18], '(Env)': [19], 'mediates': [20], 'viral': [21, 79], 'attachment': [22], 'to': [23, 117], 'and': [24, 30, 56], 'entry': [25, 102], 'in': [26, 54, 83, 110], 'susceptible': [27], 'target': [28, 35], 'cells': [29], 'therefore': [32], 'attractive': [34], 'for': [36, 51, 61, 66, 101], 'therapeutic': [37], 'intervention.': [38], 'T20': [40], 'peptide': [41], '(Fuzeon,': [42], 'enfuvirtide),': [43], 'targeting': [44, 93], 'Env': [46], 'fusion': [47], 'machinery,': [48], 'was': [49], 'approved': [50], 'clinical': [52], 'use': [53], '2003': [55], 'served': [57], 'as': [58], 'salvage': [59], 'therapy': [60], 'many': [62], 'infected': [64], 'individuals': [65], 'whom': [67], 'no': [68], 'other': [69], 'effective': [70], 'inhibitors': [71], 'were': [72], 'available': [73, 116], 'because': [74], 'of': [75, 78, 85, 113], 'development': [77], 'resistance.': [80], 'approval': [82], '2007': [84], 'small': [87], 'molecule': [88], 'inhibitor': [89], 'maraviroc': [90], '(Selzentry,': [91], 'Celsentri),': [92], 'coreceptor': [95], 'CCR5,': [96], 'marked': [97], 'a': [98, 107], 'new': [99], 'era': [100], 'inhibitors,': [103], 'which': [104], 'now': [105], 'occupy': [106], 'mature': [108], 'position': [109], 'repertoire': [112], 'antiviral': [114], 'drugs': [115], 'clinicians': [118]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2470591393', 'counts_by_year': [], 'updated_date': '2025-01-23T03:35:45.280237', 'created_date': '2016-07-22'}